MetLife stock holds above $96 as analysts see upside to $102
Published on 08/29/2026 at 15:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
MetLife Inc. (US59156R1086) stock is trading in the mid-$90 range, with recent market data showing the shares at $96.51 at the close on August 28, 2026, and a modest gain in after-hours trading that lifted the price to $97.91 as of 7:49 p.m. ET on the same date. This keeps MetLife comfortably below the average analyst price target of $102.21, leaving headroom that many investors view as potential upside.
Price level and same-day market context
Recent market data show MetLife at $96.51 at the close on August 28, 2026, reflecting a daily gain of 0.27% and signaling a relatively steady trading session for the stock. In the after-hours session on August 28, 2026, the shares moved higher to $97.91, adding 1.45% on top of the regular-session performance and suggesting ongoing interest from investors beyond standard trading hours. A separate technical overview lists the latest price signal at 96.51 USD, aligned with the August 29, 2026 data snapshot, underlining that the current trading range is clustered around the mid-$90s level.
Comparing this price with the longer-term valuation picture, one recent multi-company dashboard assigns MetLife a market capitalization of $60.9 billion as of August 29, 2026, alongside a price-to-earnings ratio of 18.26 and a profit margin of 25.55%. The same overview indicates a five-year return of 53.34% for MetLife shares and a dividend yield of 2.42%, numbers that frame the stock as a relatively established income and total-return vehicle in the US insurance segment. For investors, the key observation is that a share price just under $100 and a $60.9 billion market cap combine with mid-teens earnings multiples and mid-20s profit margins to create a valuation profile that is neither excessively cheap nor extended by sector standards.
Analyst view and positioning versus targets
MetLife's positioning relative to analyst expectations is a central point for the current investment narrative. One recent portfolio and ratings summary notes that the company carries an average recommendation categorized as a buy, with an average price target of $102.21 per share. With the stock closing at $96.51 on August 28, 2026 and trading at $97.91 in after-hours, this implies a gap of $5.70 between the close and the consensus target, or roughly 5.9% potential upside to the average price objective based on the regular-session price.
From a risk-reward perspective, the same data set pairs the $60.9 billion market cap and 18.26 price-to-earnings ratio with a profit margin of 25.55%, indicating that MetLife has been converting a quarter of its revenue into net profit over the measured period. The five-year return of 53.34% means that long-term holders have seen more than half-again appreciation over that timeframe, even before including dividends, while the 2.42% dividend yield offers ongoing income. With the shares currently trading below the consensus target yet supported by solid profitability metrics and a multi-year total-return track record, analysts' buy stance aligns with the view that MetLife may still have room to advance if it continues to execute on its operating plans.
Recent earnings context and fundamentals
From an earnings and fundamentals standpoint, the latest consolidated multi-company metrics emphasize MetLife's ability to generate consistent profits and maintain margin strength in the insurance and financial-services space. The profit margin figure of 25.55% referenced in recent comparative data, taken together with the 18.26 price-to-earnings ratio, points to a company that has converted a significant share of its top line into bottom-line earnings in the most recently reported period. While detailed quarterly figures for MetLife's own revenue and earnings per share are not enumerated in these same-day dashboards, the combination of a mid-teens valuation multiple and mid-20s profit margin illustrates that the most recent results were sufficiently strong to support a buy-leaning analyst consensus and a five-year share price gain of 53.34%.
Investors also pay close attention to dividend policy and capital-return strategy when assessing an insurer like MetLife. The current dividend yield of 2.42%, derived from recent market data and payout information, indicates that shareholders receive an annual cash return equivalent to 2.42% of the share price in the form of dividends, on top of any price appreciation. Against a backdrop of a more than 50% total return over five years, this blend of income and growth contributes to the perception that MetLife shares offer a balanced profile, provided the company continues to deliver stable earnings and maintains its distribution mindset.
Representative product and business focus
MetLife Inc. is best known for its life insurance and retirement products, with its US operations offering policies that provide financial protection for households and long-term savings vehicles such as annuities. A typical product example is a long-term life insurance policy designed to replace income and cover major expenses in case of the policyholder's death, giving beneficiaries a lump-sum payout that can support mortgage payments, education costs, and everyday living expenses. These core offerings remain central to MetLife's business model and revenue base, as the company seeks to combine underwriting discipline with investment management to generate the earnings and margins reflected in its latest financial metrics.
Stock level and investor takeaway
As of the latest data spanning the close on August 28, 2026 and subsequent after-hours trading, MetLife stock changes hands in the $96.51 to $97.91 range in USD on the New York Stock Exchange. With a market capitalization of $60.9 billion as of August 29, 2026, a price-to-earnings ratio of 18.26, a profit margin of 25.55%, a five-year return of 53.34%, and an average analyst price target of $102.21, the shares sit modestly below consensus value estimates while reflecting a multi-year record of solid performance backed by income through a 2.42% dividend yield.
Fact box
Company: MetLife Inc.
ISIN: US59156R1086
Ticker: MET
Exchange: NYSE
Price (as of August 28, 2026, 4:00 p.m. ET): $96.51 USD
Market cap: $60.9 billion (as of August 29, 2026)
Sector / Industry: Financials / Insurance
Index membership: S&P 500
